GlassScriptPhysician profile
Victoria Phan
NPI 1104484989
$502.55
in general payments reported to CMS, 2019-2025
15 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $92.17 · 2024: $195 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $120.24 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $70.78 | 2023-2025 | Slynd |
| Integra Lifesciences Corporation | $45.92 | 2023-2024 | Medihoney, Biofix, Biodoptix |
| Minerva Surgical, INC | $34.40 | 2024 | |
| Hologic Sales and Service, LLC | $33.03 | 2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Astellas Pharma US INC | $31.84 | 2024-2025 | Veozah |
| Medtronic, INC. | $27.00 | 2024 | V-Loc 180 |
| Lilly USA, LLC | $25.84 | 2023 | Taltz |
| Supernus Pharmaceuticals, INC. | $20.74 | 2025 | Qelbree |
| Organon LLC | $20.35 | 2024 | |
| Amgen INC. | $20.32 | 2025 | Evenity |
| Boston Scientific Corporation | $18.22 | 2024 | |
| Pfizer INC. | $16.93 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.04 | 2023 | Lynparza |
| Mission Pharmacal Company | $2.90 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.